Northern Cancer Institute
Frenchs Forest, New South Wales, Australia
Oncologist in Frenchs Forest, New South Wales
49 Frenchs Forest Rd E, Frenchs Forest NSW 2086
About Northern Cancer Institute
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Australian and New Zealand Urogenital and Prostate Cancer Trials Group
2
Clinical Trials at Northern Cancer Institute
During the past decade, Northern Cancer Institute conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Phase II Sequential Treatment Trial of Single Agent Nivolumab, Then Combination Ipilimumab + Nivolumab in Metastatic or Unresectable Non-Clear Cell Renal Cell Carcinoma (ANZUP1602)
2017-10-19
2022-12-31
Active, not recruiting
85
Denosumab and Pembrolizumab in Clear Cell Renal Carcinoma
2017-12-12
2023-06-04
Active, not recruiting
59
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Northern Cancer Institute"
#1 collaborator was "Amgen" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Northern Cancer Institute
According to Clinical.Site data, the most researched conditions in "Northern Cancer Institute" are
"Chromophobe Renal Cell Carcinoma" (1 trials), "Metastatic Kidney Cancer" (1 trials), "Papillary Renal Cell Carcinoma Type 1" (1 trials), "Papillary Renal Cell Carcinoma Type 2" (1 trials) and "Renal Cell Carcinoma" (1 trials). Many other conditions were trialed in "Northern Cancer Institute" in a lesser frequency.
Clinical Trials Intervention Types at Northern Cancer Institute
Most popular intervention types in "Northern Cancer Institute" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Ipilimumab" (1 trials), "Nivolumab" (1 trials) and "Pembrolizumab plus denosumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Northern Cancer Institute
The vast majority of trials in "Northern Cancer Institute" are
2 trials for "All" genders.
Clinical Trials Status at Northern Cancer Institute
Currently, there are NaN active trials in "Northern Cancer Institute".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Northern Cancer Institute,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Northern Cancer Institute, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".